Cargando…
Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus
Human norovirus is the leading cause of acute nonbacterial gastroenteritis in people of all ages worldwide. Currently, no licensed norovirus vaccine, pharmaceutical drug, or therapy is available for the control of norovirus infection. Here, we used a rice transgenic system, MucoRice, to produce a va...
Autores principales: | Sasou, Ai, Yuki, Yoshikazu, Kurokawa, Shiho, Sato, Shintaro, Goda, Yuki, Uchida, Masao, Matsumoto, Naomi, Sagara, Hiroshi, Watanabe, Yuji, Kuroda, Masaharu, Sakon, Naomi, Sugiura, Kotomi, Nakahashi-Ouchida, Rika, Ushijima, Hiroshi, Fujihashi, Kohtaro, Kiyono, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047661/ https://www.ncbi.nlm.nih.gov/pubmed/33868338 http://dx.doi.org/10.3389/fpls.2021.639953 |
Ejemplares similares
-
Mucosal vaccines: wisdom from now and then
por: Kiyono, Hiroshi, et al.
Publicado: (2021) -
Human Norovirus Propagation in Human Induced Pluripotent Stem Cell–Derived Intestinal Epithelial Cells
por: Sato, Shintaro, et al.
Publicado: (2018) -
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
por: Yuki, Yoshikazu, et al.
Publicado: (2022) -
Comparative whole-genome and proteomics analyses of the next seed bank and the original master seed bank of MucoRice-CTB 51A line, a rice-based oral cholera vaccine
por: Sasou, Ai, et al.
Publicado: (2021) -
Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases
por: Nakahashi-Ouchida, Rika, et al.
Publicado: (2018)